Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.92 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.92 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.50 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.50 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 6/20 | 0.45 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | AMY2A | P04746 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | GJA1 | P17302 | 1/20 | 0.41 |
| ▸ | GJB2 | P29033 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactulose SCHEMBL8437954 | 0.96 | MEN1 (0.85) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL8946716 | 0.96 | MEN1 (0.85) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL15942980 | 0.96 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL15942982 | 0.96 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL19194420 | 0.96 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL11892653 | 0.96 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL12787176 | 0.96 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL18479188 | 0.96 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL11890264 | 0.96 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Lactulose SCHEMBL17241809 | 0.96 | MEN1 (1.00) | MEN1KMT2ALGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034202-A1 | PAYLOAD DELIVERY SYSTEM | IMPERIAL COLLEGE INNOVATIONS LTD (GB) | 2026-02-05 | — | — | US | claimed |
| US-20250361490-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA | CELLVIE AG (CH) | 2025-11-27 | — | — | US | claimed |
| EP-4535996-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA | cellvie AG (CH) | 2025-04-16 | — | — | EP | claimed |
| EP-4529477-A1 | POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS | Danmarks Tekniske Universitet (DK) | 2025-04-02 | — | — | EP | claimed |
| EP-4448741-A2 | LIPASE FORMULATIONS AND METHODS THEREOF | First Wave Biopharma, Inc. (US) | 2024-10-23 | — | — | EP | claimed |
| EP-4447999-A1 | STABLE LIPASE FORMULATIONS AND METHODS THEREOF | First Wave Biopharma, Inc. (US) | 2024-10-23 | — | — | EP | claimed |
| EP-4429712-A1 | PAYLOAD DELIVERY SYSTEM | Imperial College Innovations Limited (GB) | 2024-09-18 | — | — | EP | claimed |
| US-20240261311-A1 | METHODS OF TREATING OR PREVENTING ALLERGIES AND CHRONIC NASAL CONGESTION | REVELATION BIOSCIENCES, INC. | 2024-08-08 | — | — | US | claimed |
| US-20240238322-A1 | THERAPEUTIC AGENTS AND METHODS OF PRODUCING SAME | Glycosynnovations Pty Ltd (AU) | 2024-07-18 | — | — | US | claimed |
| WO-2023114383-A9 | STABLE LIPASE FORMULATIONS AND METHODS THEREOF | First Wave BioPharma, Inc. (US) | 2024-07-04 | — | — | WO | claimed |
| WO-2022251455-A1 | METHODS OF TREATING OR PREVENTING ALLERGIES AND CHRONIC NASAL CONGESTION | REVELATION BIOSCIENCES, INC. (US) | 2022-12-01 | — | — | WO | claimed |
| CN-115144512-A | Used for collecting biological molecules stabilized and eluted substrates and methods | 环球生命科学解决方案运营英国有限公司 | 2022-10-04 | — | — | CN | claimed |
| WO-2022192059-A1 | SOLUTIONS AND METHODS FOR LONG-TERM POLLEN STORAGE | MONSANTO TECHNOLOGY LLC (US) | 2022-09-15 | — | — | WO | claimed |
| US-20220279778-A1 | SOLUTIONS AND METHODS FOR LONG-TERM POLLEN STORAGE | MONSANTO TECHNOLOGY LLC (US) | 2022-09-08 | — | — | US | claimed |
| US-20220240499-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF CELLS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2022-08-04 | — | — | US | claimed |
| US-20220228186-A1 | COMPOSITIONS AND METHODS FOR PRODUCING STEVIOL GLYCOSIDES | ARZEDA CORP. | 2022-07-21 | — | — | US | claimed |
| CN-108473932-B | Systems, methods, and devices for sample collection, stabilization, and preservation | 集联健康有限公司 | 2022-07-15 | — | — | CN | claimed |
| EP-3973069-A1 | COMPOSITIONS AND METHODS FOR PRODUCING STEVIOL GLYCOSIDES | Arzeda Corp. (US) | 2022-03-30 | — | — | EP | claimed |
| US-20220071196-A1 | System and method for cryopreservation of tissues | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2022-03-10 | — | — | US | claimed |
| EP-3962267-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF CELLS | Regents of the University of Minnesota (US) | 2022-03-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034202-A1 | PAYLOAD DELIVERY SYSTEM | TLR9, TLR2, TLR3 | MEN1 3450/4885KMT2A 2124/4885LGALS8 107/4885 |
| US-20220240499-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF CELLS | MUC1, MAN1B1, ADH1C | MEN1 2278/4885KMT2A 3235/4885LGALS8 70/4885 |
| US-20240238322-A1 | THERAPEUTIC AGENTS AND METHODS OF PRODUCING SAME | SIGLEC7, FUT5, UGCG | MEN1 1002/4885KMT2A 3750/4885LGALS8 47/4885 |
| US-20240261311-A1 | METHODS OF TREATING OR PREVENTING ALLERGIES AND CHRONIC NASAL CONGESTION | CPA3, MTNR1A, MRGPRX1 | MEN1 1738/4885KMT2A 1287/4885LGALS8 1114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.